亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

廣東省深圳市石金谷科技有限公司市場部  

化工原料 醫藥中間體 食品添加劑

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:周杰
  • 電話:0755-61930352
  • 郵件:sz07@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880509
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 鹽.酸莫西沙星生產廠家CAS: 186826-86-8
鹽.酸莫西沙星生產廠家CAS: 186826-86-8
單價 1.00 / kg對比
銷量 暫無
發貨 廣東深圳市付款后3天內
庫存 1000kg起訂1kg
品牌 SJG
型號 CAS: 186826-86-8
規格 98.0~102.0%
過期 長期有效
更新 2013-08-29 17:43
 
詳細信息


鹽.酸莫西沙星
莫西沙星***/1-環丙基-7-(S,S-2,8-二氮雜雙環[4.3.0]壬烷-8-基)-6-氟-8-甲氧-4-氧代-1,4-二氫-3-喹啉羧酸***
英文名稱: Moxifloxacin hydrochloride
英文同義詞: AVALOX;BAY-12-8039;ACTIRA;PROFLOX;MOXIFLOXACIN HCL
CAS號:  186826-86-8
分子式: C21H25ClFN3O4
分子量: 437.89
含量: 98.0~102.0%
包裝: 1公斤鋁箔袋 25公斤紙板桶
性狀: 淡黃色固體粉末
用途: 氟喹諾酮類抗菌藥,用于治療社區獲得性肺炎,慢性支氣管炎急性發作,泌尿生殖系感染,急性鼻竇炎,療效顯著,不良反應小

©2025 廣東省深圳市石金谷科技有限公司市場部 版權所有   技術支持:化工網   訪問量:25325  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |